Form 4 for GH Guardant Health, Inc.
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-15 · accession 0001576280-23-000105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-15 | GH | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +4,879 | 9,040 | +117% | $0 |
| D | 2023-06-16 | 2023-06-15 | GH | Freeman Chris | Chief Commercial Off | F - Tax | $37.86 | -1,346 | 7,694 | -15% | -$51.0K |
| D | 2023-06-16 | 2023-06-15 | GH | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | -4,879 | 9,758 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2023-06-15 | M | A | 4,879 | $0.00 | 9,040 | D | — | — | |
| 2 | Common | COMMON STOCK | 2023-06-15 | F | D | 1,346 | $37.86 | 7,694 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Derivative | RESTRICTED STOCK UNITS | 2023-06-15 | M | D | 4,879 | $0.00 | 9,758 | D | $0.00 · — to — | 4,879 COMMON STOCK | (F2) The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter. (F3) Not applicable to Restricted Stock Units |